DK0565512T3 - Fremgangsmåde til aktivering af blodkoagulationsfaktorer - Google Patents

Fremgangsmåde til aktivering af blodkoagulationsfaktorer

Info

Publication number
DK0565512T3
DK0565512T3 DK93890047T DK93890047T DK0565512T3 DK 0565512 T3 DK0565512 T3 DK 0565512T3 DK 93890047 T DK93890047 T DK 93890047T DK 93890047 T DK93890047 T DK 93890047T DK 0565512 T3 DK0565512 T3 DK 0565512T3
Authority
DK
Denmark
Prior art keywords
blood coagulation
coagulation factors
activating blood
trypsin
immobilised
Prior art date
Application number
DK93890047T
Other languages
English (en)
Inventor
Yendra Dr Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0565512T3 publication Critical patent/DK0565512T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK93890047T 1992-04-06 1993-03-19 Fremgangsmåde til aktivering af blodkoagulationsfaktorer DK0565512T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0071392A AT396937B (de) 1992-04-06 1992-04-06 Verfahren zur aktivierung von blutgerinnungsfaktoren

Publications (1)

Publication Number Publication Date
DK0565512T3 true DK0565512T3 (da) 1999-08-23

Family

ID=3497847

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93890047T DK0565512T3 (da) 1992-04-06 1993-03-19 Fremgangsmåde til aktivering af blodkoagulationsfaktorer

Country Status (15)

Country Link
US (1) US5393666A (da)
EP (1) EP0565512B1 (da)
JP (1) JP2723445B2 (da)
AT (2) AT396937B (da)
AU (1) AU663573B2 (da)
CA (1) CA2092158A1 (da)
CZ (1) CZ279602B6 (da)
DE (1) DE59309217D1 (da)
DK (1) DK0565512T3 (da)
ES (1) ES2125971T3 (da)
FI (1) FI106562B (da)
HU (1) HU216316B (da)
NO (1) NO306351B1 (da)
PL (1) PL298391A1 (da)
SK (1) SK281266B6 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK83092D0 (da) * 1992-06-24 1992-06-24 Unes As Fremgangsmaade til udvinding af thrombin
US5795780A (en) * 1993-06-23 1998-08-18 Bristol-Myers Squibb Company Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
AT404597B (de) 1995-11-24 1998-12-28 Immuno Ag Verfahren zur herstellung von proteinen
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US5844087A (en) * 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6461834B1 (en) 1998-11-06 2002-10-08 Bionebraska, Inc. Clostripain catalyzed amidation of peptides
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
DK1966371T3 (da) * 2005-12-22 2011-12-12 Zymogenetics Inc Fremgangsmåde til aktivering af prethrombin-1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757992A1 (de) * 1977-12-24 1979-06-28 Boehringer Mannheim Gmbh Verfahren zur prothrombin-bestimmung
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
JPS59225064A (ja) * 1983-06-03 1984-12-18 ユニチカ株式会社 生理活性物質固定化用担体
AT385657B (de) * 1984-03-09 1988-05-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
EP0294851A3 (de) * 1987-06-12 1990-05-09 Berlin-Chemie Ag Verfahren zur Herstellung von Humaninsulin und seinen Derivaten

Also Published As

Publication number Publication date
AU663573B2 (en) 1995-10-12
PL298391A1 (en) 1993-10-18
HU216316B (hu) 1999-06-28
AU3562293A (en) 1993-10-07
CZ53193A3 (en) 1994-01-19
FI106562B (fi) 2001-02-28
US5393666A (en) 1995-02-28
NO306351B1 (no) 1999-10-25
SK30893A3 (en) 1993-11-10
EP0565512A1 (de) 1993-10-13
CA2092158A1 (en) 1993-10-07
FI931554L (fi) 1993-10-07
NO931221D0 (no) 1993-03-31
SK281266B6 (sk) 2001-01-18
HUT68586A (en) 1995-06-28
DE59309217D1 (de) 1999-01-28
ATA71392A (de) 1993-05-15
HU9300753D0 (en) 1993-06-28
FI931554A0 (fi) 1993-04-06
ES2125971T3 (es) 1999-03-16
JP2723445B2 (ja) 1998-03-09
EP0565512B1 (de) 1998-12-16
AT396937B (de) 1993-12-27
JPH0686674A (ja) 1994-03-29
ATE174624T1 (de) 1999-01-15
CZ279602B6 (cs) 1995-05-17
NO931221L (no) 1993-10-07

Similar Documents

Publication Publication Date Title
DE3788353D1 (de) Vorrichtung und verfahren zur musternahme von arteriellem und venösem blut.
DE68922191D1 (de) Verfahren zur Produktion von Akrylat und von Akrylat enthaltendem Polymer.
DE69329108D1 (de) Verfahren zur inaktivierung von viren
ATE161681T1 (de) Verfahren zur inaktivierung von viren in blut und blutprodukten
ATE299396T1 (de) Verfahren zur verbesserung der aktivität von katalysatoren
DE69100456D1 (de) Verfahren zur Vorschwefelung von Kohlenwasserstoffbehandlungskatalysatoren.
DK0565512T3 (da) Fremgangsmåde til aktivering af blodkoagulationsfaktorer
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
ATA902789A (de) Verfahren zur katalytischen behandlung von abwasser
DE68918083D1 (de) Verfahren zur reinigung von blutplasma.
DE59106383D1 (de) Verfahren und einrichtung zur oxidation von wasserstoff.
DE69017997D1 (de) Katalysator zur Oxydation von Kohlenmonoxid.
DE3761370D1 (de) Verfahren zur aktivierung von wasserstoffperoxid zur oxidationsbehandlung von schwer abbaubaren toxischen substanzen.
DE68903208D1 (de) Verfahren zur thermischen behandlung von laktoferrin.
DE68905393D1 (de) Verfahren zur oxydierung von ungesaettigten aromatischen verbindungen.
ATE85600T1 (de) Verfahren zur herstellung von nabumeton.
DE3781279D1 (de) Verfahren zur behandlung von blut.
DE3761760D1 (de) Verfahren zur aufbereitung von cyclohexylhydroperoxid enthaltenden reaktionsgemischen.
DE58902978D1 (de) Verfahren zur katalytischen oxidation von schwefelwasserstoff.
DE3764020D1 (de) Verfahren zur katalytischen hydrobehandlung von kohlenwasserstoffen.
DE3764168D1 (de) Verfahren zur katalytischen hydrobehandlung von kohlenwasserstoffen.
DE68910033D1 (de) Katalytisches Verfahren zur Herstellung von optisch-aktiven Alpha-Hydroxycarboxylaten.
ATE99706T1 (de) Adhaesivkomponente zur behandlung kollagenhaltiger materialien.
DE69021584D1 (de) Behandlung von abgas.
DK0453473T3 (da) Bærer til selektiv immunorensning og fremgangsmåde til behandling af denne bærer